Resting Heart Rate and the Risk of Microvascular Complications in Patients With Type 2 Diabetes Mellitus

被引:55
作者
Hillis, Graham S. [1 ]
Hata, Jun [1 ]
Woodward, Mark [1 ]
Perkovic, Vlado [1 ]
Arima, Hisatomi [1 ]
Chow, Clara K. [1 ]
Zoungas, Sophia [1 ]
Patel, Anushka [1 ]
Poulter, Neil R. [2 ]
Mancia, Giuseppe [4 ]
Williams, Bryan [3 ]
Chalmers, John [1 ]
机构
[1] Univ Sydney, George Inst Global Hlth, Sydney, NSW 2006, Australia
[2] Univ London Imperial Coll Sci Technol & Med, London, England
[3] UCL, London, England
[4] Univ Milano Bicocca, Milan, Italy
来源
JOURNAL OF THE AMERICAN HEART ASSOCIATION | 2012年 / 1卷 / 05期
基金
英国医学研究理事会;
关键词
diabetes mellitus; type; 2; heart rate; microcirculation; NOCTURNAL BLOOD-PRESSURE; CARDIOVASCULAR EVENTS; ATRIAL-FIBRILLATION; MICROALBUMINURIA; DISEASE; ASSOCIATION; RETINOPATHY; MORTALITY; DEATH; INDIVIDUALS;
D O I
10.1161/JAHA.112.002832
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background-A higher resting heart rate is associated with an increased probability of cardiovascular complications and premature death in patients with type 2 diabetes mellitus. The impact of heart rate on the risk of developing microvascular complications, such as diabetic retinopathy and nephropathy, is, however, unknown. The present study tests the hypothesis that a higher resting heart rate is associated with an increased incidence and a greater progression of microvascular complications in patients with type 2 diabetes mellitus. Methods and Results-The relation between baseline resting heart rate and the development of a major microvascular event was examined in 11 140 patients who participated in the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation (ADVANCE) study. Major microvascular events were defined as a composite of new or worsening nephropathy or new or worsening retinopathy. Patients with a higher baseline heart rate were at increased risk of a new major microvascular complication during follow-up (adjusted hazard ratio: 1.13 per 10 beats per minute; 95% confidence interval: 1.07-1.20; P<0.001). The excess hazard was evident for both nephropathy (adjusted hazard ratio: 1.16 per 10 beats per minute; 95% confidence interval: 1.08-1.25) and retinopathy (adjusted hazard ratio: 1.11 per 10 beats per minute; 95% confidence interval: 1.02-1.21). Conclusion-Patients with type 2 diabetes mellitus who have a higher resting heart rate experience a greater incidence of new-onset or progressive nephropathy and retinopathy.
引用
收藏
页数:11
相关论文
共 43 条
[1]   Standards of medical care in diabetes 2008 [J].
不详 .
DIABETES CARE, 2008, 31 :S12-S54
[2]  
[Anonymous], NEW ENGL J MED
[3]  
[Anonymous], EPIDEMIOLOGY STUDY D
[4]   Low-grade albuminuria and incidence of cardiovascular disease events in nonhypertensive and nondiabetic individuals -: The Framingham heart study [J].
Ärnlöv, J ;
Evans, JC ;
Meigs, JB ;
Wang, TJ ;
Fox, CS ;
Levy, D ;
Benjamin, EJ ;
D'Agostino, RB ;
Vasan, RS .
CIRCULATION, 2005, 112 (07) :969-975
[5]  
Böhm M, 2008, J HYPERTENS, V26, P18
[6]   Atrial fibrillation and heart rate independently correlate to microalbuminuria in hypertensive patients [J].
Boehm, Michael ;
Thoenes, Martin ;
Neuberger, Hans-Ruprecht ;
Graeber, Stefan ;
Reil, Jan-Christian ;
Bramlage, Peter ;
Volpe, Massimo .
EUROPEAN HEART JOURNAL, 2009, 30 (11) :1364-1371
[7]   Heart Rate Variability Predicts ESRD and CKD-Related Hospitalization [J].
Brotman, Daniel J. ;
Bash, Lori D. ;
Qayyum, Rehan ;
Crews, Deidra ;
Whitsel, Eric A. ;
Astor, Brad C. ;
Coresh, Josef .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2010, 21 (09) :1560-1570
[8]   Prospective investigation of autonomic nervous system function and the development of type 2 diabetes - The Atherosclerosis Risk in Communities study, 1987-1998 [J].
Carnethon, MR ;
Golden, SH ;
Folsom, AR ;
Haskell, W ;
Liao, DP .
CIRCULATION, 2003, 107 (17) :2190-2195
[9]   The heart rate story [J].
Ceconi, Claudio ;
Guardigli, Gabriele ;
Rizzo, Paola ;
Francolini, Gloria ;
Ferrari, Roberto .
EUROPEAN HEART JOURNAL SUPPLEMENTS, 2011, 13 (0C) :C4-C13
[10]  
Chalmers J, 2001, DIABETOLOGIA, V44, P1118